Home CytomX IPO Could Pop, But Long-Term Returns Are Uncertain
 

Keywords :   


CytomX IPO Could Pop, But Long-Term Returns Are Uncertain

2015-10-07 21:20:52| Biotech - Topix.net

CytomX Therapeutics expects to raise $100 million in its upcoming IPO. Based in South San Francisco, California, CytomX Therapeutics is a biopharmaceutical company focused on developing treatments for cancer.

Tags: pop returns ipo uncertain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05M&S website and app hit by technical issue
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Producers to be paid grid premiums for AngusLink beef scores
18.05This Week in Agribusiness, May 18, 2024
18.05This Week in Agribusiness, May 18, 2024
More »